Goldman Sachs’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.3M | Buy |
1,886,691
+451,493
| +31% | +$4.37M | ﹤0.01% | 1833 |
|
|
2025
Q1 | $21.4M | Buy |
1,435,198
+801,307
| +126% | +$11.9M | ﹤0.01% | 1653 |
|
|
2024
Q4 | $9.46M | Buy |
633,891
+19,400
| +3% | +$289K | ﹤0.01% | 2375 |
|
|
2024
Q3 | $11.8M | Sell |
614,491
-300,562
| -33% | -$5.75M | ﹤0.01% | 2126 |
|
|
2024
Q2 | $18.9M | Buy |
915,053
+363,630
| +66% | +$7.53M | ﹤0.01% | 1633 |
|
|
2024
Q1 | $10.4M | Buy |
551,423
+131,666
| +31% | +$2.48M | ﹤0.01% | 2025 |
|
|
2023
Q4 | $6.05M | Sell |
419,757
-1,088,678
| -72% | -$15.7M | ﹤0.01% | 2463 |
|
|
2023
Q3 | $26.2M | Sell |
1,508,435
-682,048
| -31% | -$11.8M | 0.01% | 1314 |
|
|
2023
Q2 | $45.6M | Buy |
2,190,483
+1,453,728
| +197% | +$30.3M | 0.01% | 1009 |
|
|
2023
Q1 | $17.3M | Buy |
736,755
+371,567
| +102% | +$8.74M | ﹤0.01% | 1632 |
|
|
2022
Q4 | $10.2M | Sell |
365,188
-231,313
| -39% | -$6.46M | ﹤0.01% | 2116 |
|
|
2022
Q3 | $14M | Buy |
596,501
+66,299
| +13% | +$1.55M | ﹤0.01% | 1873 |
|
|
2022
Q2 | $17.9M | Sell |
530,202
-636,522
| -55% | -$21.5M | ﹤0.01% | 1686 |
|
|
2022
Q1 | $40.8M | Buy |
1,166,724
+408,618
| +54% | +$14.3M | 0.01% | 1225 |
|
|
2021
Q4 | $23.1M | Sell |
758,106
-518,838
| -41% | -$15.8M | ﹤0.01% | 1656 |
|
|
2021
Q3 | $41.9M | Buy |
1,276,944
+31,495
| +3% | +$1.03M | 0.01% | 1207 |
|
|
2021
Q2 | $37.7M | Buy |
+1,245,449
| New | +$37.7M | 0.01% | 1284 |
|